Last reviewed dd mmm yyyy. Last edited dd mmm yyyy
Teriflunomide is an immunomodulatory disease-modifying therapy
Adverse effects include:
NICE have stated that teriflunomide is recommended for treating adults with active relapsing-remitting multiple sclerosis (normally defined as 2 clinically significant relapses in the previous 2 years)
For full details see the summary of product characteristics.
Reference:
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.